NCT03416153 2025-05-22
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
Clinical Trials
3 trialsNCT03715946 2025-01-13
Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer
University of Pittsburgh
Phase 2 Completed
NCT01525927 2017-12-19
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
Northwell Health
Phase 2 Terminated